# Osteomyelitis

Osteomyelitis management depends on anatomic syndrome, microbiologic confirmation, source control, and a feasible antimicrobial route. In diabetic foot disease, probe-to-bone, radiography, MRI, and bone biopsy guide diagnosis; selected patients can receive medical therapy or conservative bone resection.

**Clinical question:** How should physicians confirm osteomyelitis and select medical versus surgical treatment, particularly in diabetes-related foot infection?

Updated: 2026-08-21T02:19:43.589751+00:00

## What matters in practice
- Treat osteomyelitis as an anatomic syndrome: diabetic foot, vertebral, pediatric acute hematogenous, chronic contiguous-focus, and fungal disease require different diagnostic and treatment pathways.[14][15][21]
- For suspected diabetic foot osteomyelitis, combine examination including probe-to-bone testing with plain radiography; MRI is the preferred advanced imaging study when diagnostic uncertainty persists.[6][16][24]
- Bone biopsy with examination of a surgical or percutaneous bone specimen is the diagnostic reference standard for diabetic foot osteomyelitis.[8][24]
- In properly selected diabetic foot osteomyelitis, either primarily medical treatment or conservative surgical bone resection is reasonable; a small randomized trial found similar healing and treatment-complication rates.[18][19]
- Do not assume intravenous therapy is intrinsically superior: oral and intravenous regimens have shown comparable outcomes in selected diabetic foot osteomyelitis cohorts, while route selection must account for clinical severity and treatment context.[10][11]

## Localize the osteomyelitis syndrome before choosing tests or treatment

The anatomic setting determines urgency, microbiologic strategy, and whether surgery is central to cure.

Separate diabetes-related foot osteomyelitis from native vertebral osteomyelitis, pediatric acute hematogenous osteomyelitis, chronic contiguous-focus disease, and suspected Candida osteomyelitis at the first assessment. These syndromes are addressed by distinct specialty guidelines or disease-specific treatment approaches; applying a diabetic-foot pathway to vertebral or pediatric hematogenous disease can misdirect imaging, sampling, and follow-up.[14][15][21]

In diabetes-related foot infection, actively assess for underlying bone involvement because osteomyelitis occurs in about 20% of diabetic foot infections and in more than 60% of severe infections; its presence substantially increases lower-extremity amputation risk.[18] Prioritize urgent operative assessment when there is devitalized or infected tissue requiring debridement, because removal of necrotic or infected tissue reduces microbial burden and supports wound healing.[1]

For native vertebral osteomyelitis, use the dedicated adult IDSA diagnostic, management, and follow-up framework rather than extrapolating from foot-infection studies.[15] For acute hematogenous osteomyelitis in children, use the PIDS/IDSA pediatric pathway, which was developed specifically for pediatric emergency, hospital, orthopedic, and infectious-diseases practice.[14]
- Diabetic foot pattern: obtain a structured foot examination, probe-to-bone assessment, plain radiographs, and a plan for deep bone sampling when confirmation will alter treatment.[6][8][24]
- Vertebral pattern: use the adult native vertebral osteomyelitis guideline pathway for diagnosis, management, and follow-up.[15]
- Pediatric acute hematogenous pattern: use the PIDS/IDSA acute hematogenous osteomyelitis pathway rather than adult chronic-osteomyelitis conventions.[14]
- Suspected Candida pattern: anticipate prolonged antifungal treatment, reported as 6 to 12 months, and consider surgery when indicated.[21]

*Anatomic syndrome directs the next diagnostic and treatment pathway.[14][15][18][21]*

| Clinical setting | Immediate diagnostic focus | Management implication |
| --- | --- | --- |
| Diabetes-related foot infection | Assess for bone involvement with probe-to-bone testing, radiography, MRI when needed, and bone biopsy for definite diagnosis.[6][16][24] | Choose medical therapy, conservative surgery, or both after defining bone involvement and source-control needs.[18][19] |
| Native vertebral osteomyelitis | Use the IDSA adult native vertebral osteomyelitis diagnostic pathway.[15] | Follow the syndrome-specific IDSA management and follow-up framework.[15] |
| Pediatric acute hematogenous osteomyelitis | Use PIDS/IDSA diagnostic recommendations for acute hematogenous disease.[14] | Use pediatric syndrome-specific treatment recommendations.[14] |
| Candida osteomyelitis | Establish fungal osteomyelitis rather than treating as routine bacterial disease.[21] | Plan extended antifungal therapy for 6 to 12 months; add surgery when indicated.[21] |

## Confirm diabetic foot osteomyelitis with escalating bedside, imaging, and bone tests

Use sequential tests to reduce uncertainty; do not equate an ulcer culture with proof of bone infection.

Begin with clinical examination and a probe-to-bone test, then obtain plain foot radiographs. Combining probe-to-bone findings with plain radiography improves diagnostic accuracy compared with either approach alone.[6] A positive probe-to-bone result should increase concern for osteomyelitis in an infected diabetic foot ulcer, but it does not replace bone sampling when a definitive diagnosis will determine prolonged antimicrobial treatment or bone resection.[2][8][24]

Use MRI when the bedside examination and radiographs do not establish the diagnosis or when defining the extent of bone involvement will change the operative plan. A meta-analysis found MRI superior to bone scans, labeled-white-cell scans, and plain radiography for diagnosing osteomyelitis.[16] MRI supports diagnostic assessment but does not supplant tissue confirmation when microbiologic or histopathologic certainty is needed.[24]

Obtain a surgical or percutaneous bone biopsy when definite diabetic foot osteomyelitis must be established, when the diagnosis remains uncertain after imaging, or when culture-directed treatment is necessary. Bone sample examination is the reference standard, and definite diagnosis is based on a surgical or percutaneous bone specimen.[8][24] Coordinate sampling with the proceduralist and microbiology laboratory so the specimen is processed as bone rather than managed as a superficial wound culture.[3][4]
- Probe-to-bone plus plain radiographs: practical initial combination that improves diagnostic accuracy.[6]
- MRI: preferred advanced imaging test when initial evaluation is indeterminate or mapping disease extent changes management.[16][24]
- Bone biopsy: reference-standard diagnostic test for definite diabetic foot osteomyelitis.[8][24]
- Inflammatory biomarkers: ESR has been characterized as an excellent biomarker for osteomyelitis detection, while CRP and procalcitonin are acceptable diagnostic biomarkers; interpret them as adjuncts rather than replacements for imaging or bone sampling.[7]

### How to use discordant results

When probe-to-bone testing or radiography suggests osteomyelitis but the consequence of misclassification is prolonged treatment or amputation-level surgery, obtain MRI to clarify distribution and pursue bone biopsy for definitive confirmation.[6][16][24] Conversely, when MRI suggests osteomyelitis but microbiology will determine a narrow oral regimen or the need for resection, bone sampling remains the decisive test.[8][24]

*Diagnostic escalation for suspected diabetic foot osteomyelitis.[6][7][8][16][24]*

| Test | Role in decision-making | Limitation or next action |
| --- | --- | --- |
| Probe-to-bone test | Bedside test supported by current guideline-oriented evidence; combine with radiographs to improve diagnostic accuracy.[2][6] | Does not establish a definite diagnosis when treatment hinges on bone confirmation; proceed to imaging or biopsy as appropriate.[8][24] |
| Plain radiography | Initial imaging test; diagnostic accuracy improves when interpreted with probe-to-bone results.[6] | MRI is more accurate than plain radiography when uncertainty persists.[16] |
| MRI | Best-performing advanced imaging modality among MRI, bone scan, white-cell scan, and radiography in a meta-analysis.[16] | Use bone biopsy when definite diagnosis or organism-directed therapy is required.[8][24] |
| ESR, CRP, procalcitonin | Adjunctive biomarkers; ESR is described as excellent, and CRP and procalcitonin as acceptable, for diagnosing osteomyelitis.[7] | Do not use biomarkers alone to replace anatomic imaging or bone sampling.[8][24] |
| Surgical or percutaneous bone biopsy | Diagnostic reference standard and basis for definite diabetic foot osteomyelitis diagnosis.[8][24] | Ensure appropriate microbiologic laboratory handling of the bone specimen.[3][4] |

## Choose antibiotics, conservative surgery, or both based on source control and limb preservation

The pivotal choice is not medical versus surgical in isolation; it is whether infected or nonviable bone can be retained safely.

Treat the infected foot as a combined infection and wound-management problem. Prompt debridement of necrotic tissue reduces microbial burden and facilitates healing, while off-loading redistributes pressure away from the ulcer to promote healing.[1] Reassess the need for operative source control whenever soft-tissue necrosis, infected tissue, or a bone burden unsuitable for retention is present.

For properly selected diabetic foot osteomyelitis, clinicians may use either a primarily medical strategy or a primarily surgical strategy.[18] In a randomized comparative study of 52 patients, 90 days of antibiotics produced complete epithelialization in 75%, compared with 86% after removal of infected bone followed by a short antibiotic course; the difference was not statistically significant, and treatment complications were similar.[19] This trial supports shared selection rather than routine bone resection for every case.

Favor a surgical pathway when debridement is already required for infected or devitalized tissue, when removal of infected bone provides needed source control, or when limb-preserving resection can reduce the amount of infected bone that must be managed medically.[1][18] Favor a primarily medical pathway when the patient is appropriately selected for bone retention and the tradeoff of prolonged antimicrobial treatment is acceptable.[18][19] Available studies have not defined every clinical subgroup that requires surgery, so reassess treatment response rather than treating the initial choice as irrevocable.[18]
- Debride necrotic or infected soft tissue promptly when present; this reduces microbial burden and supports healing.[1]
- Use off-loading as a wound-healing intervention in diabetic foot disease.[1]
- Consider either medical or conservative surgical treatment for selected diabetic foot osteomyelitis rather than presuming one strategy is universally superior.[18][19]
- After amputation with residual osteomyelitis at positive margins, oral therapy was not associated with a statistically significant difference in treatment failure compared with intravenous therapy in a retrospective cohort.[10]

### Antimicrobial route: make oral therapy an active choice

Do not select intravenous therapy solely because bone is involved. A retrospective study of residual diabetic foot osteomyelitis after amputation found no statistically significant difference in treatment failure between oral and intravenous therapy.[10] A scoping review likewise found comparable clinical outcomes across oral and intravenous studies, although most included studies were retrospective observational cohorts and evidence gaps remain.[11]

Use oral therapy only when the patient is clinically suitable for outpatient oral treatment and the regimen can be selected around the clinical presentation and care context.[11] Intravenous therapy remains appropriate when the presentation or care setting requires it, but the route should be reassessed after source control and once a reliable oral treatment plan is feasible.[10][11]
- Oral versus intravenous therapy: comparable outcomes have been reported in selected diabetic foot osteomyelitis populations, but evidence quality is limited by predominantly observational studies.[10][11]
- Residual post-amputation osteomyelitis: oral therapy was not inferior to intravenous therapy in one retrospective cohort.[10]
- Route selection: base the decision on patient presentation and care context, not on a presumption that intravenous delivery improves bone outcomes.[11]

*Medical and surgical strategies for selected diabetic foot osteomyelitis.[1][10][11][18][19]*

| Strategy | When it fits | Key tradeoff |
| --- | --- | --- |
| Primarily medical treatment | Appropriately selected patients in whom bone retention is acceptable.[18][19] | Requires sustained antimicrobial management and close reassessment for failure or need for source control.[18] |
| Conservative bone resection plus antibiotics | When infected bone can be removed as part of limb-preserving source control.[18][19] | May shorten residual bone burden but introduces operative tissue-loss and healing considerations.[18] |
| Debridement of necrotic or infected tissue | Indicated when devitalized or infected tissue requires removal.[1] | Essential wound and source-control intervention; it does not eliminate the need to define underlying bone infection.[1][8] |
| Oral antimicrobial route | Selected patients with a feasible oral regimen and appropriate clinical context.[10][11] | Evidence suggests comparable outcomes to intravenous therapy in selected populations, but much diabetic-foot evidence is observational.[10][11] |
| Intravenous antimicrobial route | Patients whose clinical presentation or care context requires parenteral treatment.[11] | Avoid assuming superiority solely from intravenous administration.[10][11] |

## Monitor the wound, source control, and treatment trajectory rather than relying on route alone

Failure to improve should trigger reassessment of diagnosis, bone burden, and adequacy of debridement.

For diabetic foot osteomyelitis, serially reassess ulcer healing, pressure redistribution, residual necrotic tissue, and the clinical need for additional debridement. Off-loading promotes ulcer healing, while debridement may need to be repeated when clinicians judge residual devitalized or infected tissue remains.[1][17] Persistent nonhealing should prompt reconsideration of the initial diagnosis and whether retained infected bone or inadequate source control is driving the course.[8][18][24]

Interpret inflammatory markers as adjunctive trends rather than stand-alone proof of cure or persistence. ESR, CRP, and procalcitonin have diagnostic roles in diabetic foot osteomyelitis, but definite diagnosis rests on bone sample examination when certainty is required.[7][8][24] If a patient treated medically has an unfavorable trajectory, obtain repeat clinical and imaging assessment and reconsider bone biopsy or conservative surgery rather than reflexively extending an empiric regimen.[16][18][24]

Use syndrome-specific follow-up frameworks outside diabetic foot disease. Native vertebral osteomyelitis has an IDSA guideline that explicitly addresses follow-up, and pediatric acute hematogenous osteomyelitis has separate PIDS/IDSA recommendations.[14][15] For Candida osteomyelitis, prolonged 6- to 12-month antifungal courses and surgery when indicated require a different monitoring horizon from routine bacterial foot infection.[21]
- Persistent ulcer or recurrent drainage: reassess off-loading, devitalized tissue, retained bone infection, and the need for operative source control.[1][18]
- Persistent diagnostic uncertainty after imaging: obtain a surgical or percutaneous bone specimen when a definite diagnosis will change management.[8][24]
- Non-foot osteomyelitis: follow native vertebral and pediatric acute hematogenous disease through their dedicated guidelines.[14][15]
- Candida osteomyelitis: plan for a prolonged 6- to 12-month antifungal treatment horizon and assess for surgical indications.[21]

*Reassessment triggers in osteomyelitis management.[1][7][8][14][15][18][21][24]*

| Finding during follow-up | Interpretation | Next action |
| --- | --- | --- |
| Persistent diabetic foot ulcer despite treatment | May reflect inadequate pressure redistribution, residual infected or necrotic tissue, or retained bone infection.[1][18] | Reassess off-loading and debridement needs; reconsider operative source control and bone confirmation.[1][8][24] |
| Biomarker abnormality without diagnostic certainty | ESR, CRP, and procalcitonin are adjunctive diagnostic markers, not definitive proof of osteomyelitis.[7] | Integrate with examination, radiography, MRI, and bone biopsy when management depends on certainty.[6][8][16][24] |
| Need for follow-up in vertebral osteomyelitis | Management and follow-up are addressed in the IDSA native vertebral osteomyelitis guideline.[15] | Use the dedicated adult vertebral osteomyelitis pathway.[15] |
| Candida identified or strongly suspected | Treatment duration and surgical considerations differ materially from routine bacterial disease.[21] | Plan extended antifungal therapy for 6 to 12 months and evaluate surgical indications.[21] |

## References
1. Diabetic Foot Infection Management Strategies | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index — www.nature.com — https://www.nature.com/nature-index/topics/l4/diabetic-foot-infection-management-strategies
2. Volume 63 Issue 7 | Clinical Infectious Diseases — academic.oup.com — https://academic.oup.com/cid/issue/63/7
3. Guide to Utilization of the Microbiology Laboratory for ... — academic.oup.com — https://academic.oup.com/cid/article/67/6/e1/5046039
4. A Guide to Utilization of the Microbiology Laboratory — academic.oup.com — https://academic.oup.com/cid/article-pdf/67/6/e1/34130303/ciy381.pdf
5. Serious Infections Caused by Methicillin-Resistant ... — academic.oup.com — https://academic.oup.com/cid/article/51/Supplement_2/S183/382346
6. IWGDF guidance on the diagnosis and management of foot ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/dmrr.2699
7. Update of biomarkers to diagnose diabetic foot ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/wrr.13174
8. Plain Radiography for Diagnosing and Monitoring Foot ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/wrr.70128
9. Is fluoroscopy‐guided percutaneous bone biopsy of ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13377
10. Oral Versus Intravenous Antibiotics for Residual Osteomyelitis After Amputation in the Diabetic Foot - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1067251621004592
11. Perspectives on antibiotic management of diabetic foot osteomyelitis: A scoping review on routes of administration — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0168822725010502
12. Are Oral Antibiotics an Effective Alternative to Intravenous Antibiotics in Treatment of Osteomyelitis of the Jaw? - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0278239121004067
13. Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0002934321006999
14. Acute Hematogenous Osteomyelitis in Pediatrics — www.idsociety.org — https://www.idsociety.org/practice-guideline/bone-and-joint-infections---osteomyelitis
15. Vertebral Osteomyelitis — www.idsociety.org — https://www.idsociety.org/practice-guideline/vertebral-osteomyelitis
16. Does This Patient With Diabetes Have Osteomyelitis of the ... — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(08)00836-6/pdf
17. national institute for health and care — www.nice.org.uk — https://www.nice.org.uk/guidance/HTG566/documents/supporting-documentation-3
18. Treating Diabetic Foot Osteomyelitis Primarily With Surgery or Antibiotics: Have We Answered the Question? | Diabetes Care | American Diabetes Association — diabetesjournals.org — https://diabetesjournals.org/care/article/37/3/593/29112/Treating-Diabetic-Foot-Osteomyelitis-Primarily
19. Antibiotics as Effective as Conservative Surgery for Diabetic Foot Osteomyelitis - OrthoBuzz — orthobuzz.jbjs.org — https://orthobuzz.jbjs.org/2014/05/02/antibiotics-as-effective-as-conservative-surgery-for-diabetic-foot-osteomyelitis
20. Systemic Antibiotic Therapy for Chronic Osteomyelitis in Adults — academic.oup.com — https://academic.oup.com/cid/article/54/3/393/304469?login=false
21. Candida Osteomyelitis: Analysis of 207 Pediatric and Adult ... — academic.oup.com — https://academic.oup.com/cid/article/55/10/1338/321695
22. History of Antibiotic Treatment of Osteomyelitis — academic.oup.com — https://academic.oup.com/ofid/article/6/5/ofz181/5432301
23. Effectiveness of Dalbavancin Compared With Standard of ... — academic.oup.com — https://academic.oup.com/ofid/article/9/2/ofab589/6469809
24. Diagnosing diabetic foot osteomyelitis - Senneville - 2020 — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3250

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.